Company Directory > CDMO > Apothecon Pharmaceuticals Pvt. Ltd.
Apothecon Pharmaceuticals is a research-led pharmaceutical company specializing in the development and manufacturing of niche APIs, peptides, and complex formulations. The company focuses on 505(b)(2) development pathways, oral solids, injectables, and nasal sprays, aiming to provide specialized, high-quality medicines for global markets. With manufacturing facilities compliant with USFDA, UK MHRA, and WHO-GMP standards, Apothecon operates as both a product developer and a CDMO partner. The company has a strong focus on rare diseases, renal care, CNS, and cardiovascular therapeutic areas, supported by advanced R&D infrastructure for bioequivalence and stability studies.
CLASSIFICATION
Company Type:CDMO
Industry:Pharmaceuticals
Sub-Industry:Complex Generics / CDMO
SIZE & FINANCIALS
Employees:501-1000
Founded:2007
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Peptides, Complex formulations
Active Trials:0
Trial Phases:-
FDA Approvals:21
EMA Approvals:0
COMPETITION
Position:Emerging
Competitors:4care Lifescience Private Limited, Amicures Research Private Limited
LEADERSHIP
Key Executives:
Dilipkumar Parmar - CFO & Executive Director
Christopher Newton Benny Job Devairakkam - Founder
Rambhai Dadabhai Patel - Founder
Scientific Founders:Christopher Newton Benny Job Devairakkam, Rambhai Dadabhai Patel
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Apothecon Pharmaceuticals Pvt. Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Apothecon Pharmaceuticals Pvt. Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.